Bayer is signaling it has had enough of litigation, leaving the future of a crop protection tool in limbo.
Executives tell the Wall Street Journal they are nearing the end of the road for glyphosate, the main ingredient in RoundUp. CEO Bill Anderson says they are barely breaking even, and litigation costs often put them in the red.
More than 65,000 cases are pending against Bayer right now, and the company has around $16 billion set aside for settlements.
Anderson stands by glyphosate, saying it has been proven safe to use, even by the FDA. Bayer produces roughly 40 percent of the supply used by U.S. farmers.
Related Stories
John Deere representative Kaylene Ballesteros took RanchHer host, Janie Johnson, on a tour of the company’s exciting, new offerings at NCBA CattleCon in Orlando.
RanchHer celebrated the invaluable contributions women leading the beef industry at their panel, “Your Path to Becoming a RanchHer,” Friday at NCBA CattleCon.
As we start the new year, let’s take a look at some of the legislative items from 2023 affecting agriculture that will continue to play out in the political area for months to come.
